Cancer
We’re investigating the biological basis of many solid and blood borne malignancies, advancing diagnosis, developing and trialing new therapies, and improving all aspects of the management of cancer including palliative care.
Program Leaders
Our Cancer Program Leaders are supported by six Cancer Program Group Leaders and a team of more than 60 group members. View a full listing of Cancer Program researchers.
Program Groups
Clinical Trials
Clinical trials are an essential component of modern healthcare and provide evidence to evaluate the safety and efficacy of new treatments, diagnostics and health interventions and offer alternative options for patients with unmet needs under current standards of care. Explore Cancer Program clinical trials currently running at Mater Research below or learn more about Mater Clinical Trials.
-
A drug comparison for patients with newly diagnosed with metastatic hormone-sensitive prostate cancer
-
A new way of taking hormone tablets for patients with prostate cancer
-
Assessing the effectiveness of DB-1303 in the treatment of HER2-low breast cancer
-
B-Cell Malignancies new treatment
-
Do you have muscle-invasive Bladder Cancer?
-
Do you have a confirmed advanced solid tumor?
-
Do you have advanced ovarian, peritoneal or fallopian tube cancer?
-
Do you have an advanced solid tumour?
-
Do you have an advanced solid tumour?
-
Do you have early breast cancer, and have had complete surgical removal of your tumour?
-
Do you have ERpositive/HER2-negative early breast cancer?
-
Do you have gynaecological cancer with hormone receptor positive disease?
-
Do you have locally advanced or metastatic non-clear cell renal cell carcinoma?
-
Do you have metastatic , HER2 negative breast cancer?
-
Do you have Metastatic ER+/HER2− Breast Cancer with an ESR1 Mutation?
-
Do you have Muscle-invasive Bladder Cancer?
-
Do you have newly diagnosed prostate cancer?
-
Do you have ovarian, peritoneal or fallopian tube cancer?
-
FOCUSau: Improving the wellbeing of people with advanced cancer and their family carers
-
Follicular Lymphoma
-
HyNOVA - Hyperthermic and Normothermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III epithelial OVArian, fallopian tube and primary peritoneal cancer
-
MedCan 3 - Medicinal cannabis to relieve symptoms of advanced cancer in palliative care patients
-
Seeking cancer patients with nerve pain
-
Testing the addition of immunotherapy in patients with endometrial cancer
